Cytek Biosciences, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Cytek Biosciences, Inc. | CTKB - NASDAQ |
$16.00-$18.00 | $17.00 | $20.10 | 16.7 million | 7/23/2021 |
| Morgan Stanley, Goldman Sachs, Piper Sandler, Cowen | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-07-02 Terms Added 2021-07-19 | ||||||
Cytek Biosciences, Inc. Quote & Chart - Click for current quote - CTKB
IPO Boutique aggregates information on public companies and private companies, such as "CTKB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Cytek Biosciences, Inc. (adapted from Cytek Biosciences, Inc. prospectus):
They are a leading cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a leading cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "CTKB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.